Alto Neuroscience (ANRO) vs Rigel Pharmaceuticals (RIGL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Alto Neuroscience (ANRO) has outperformed Rigel Pharmaceuticals (RIGL) over the past year, gaining 296.0% versus a gain of 62.7%. Alto Neuroscience is the larger company by market cap ($923.0 million vs $896.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANRO | RIGL |
|---|---|---|
| Share price | $23.52 | $47.99 |
| Market cap | $922.97M | $896.45M |
| 1-day change | -0.72% | +4.08% |
| YTD return | +32.13% | +12.05% |
| 1-year return | +295.96% | +62.68% |
| 5-year return | — | +41.98% |
| P/E ratio (TTM) | — | 2.84 |
| Forward P/E | — | 9.72 |
| EPS (TTM) | $-2.31 | $16.88 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $37.48 | $52.24 |
| 52-week low | $5.23 | $24.95 |
| Distance from 52-week high | -37.25% | -8.14% |
| Average volume | 543.14K | 291.58K |
| Shares outstanding | 39.24M | 18.68M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANRO has outperformed RIGL by 233.3 percentage points over the past year.
ANRO vs RIGL FAQ
Which is bigger, Alto Neuroscience or Rigel Pharmaceuticals?
Alto Neuroscience (ANRO) is larger, with a market capitalization of $922.97M compared with $896.45M for Rigel Pharmaceuticals (RIGL).
Which stock has performed better over the past year, ANRO or RIGL?
ANRO returned +295.96% over the past 12 months, compared with +62.68% for RIGL (price return, excluding dividends). Past performance does not predict future results.
Are Alto Neuroscience and Rigel Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.